questionsmedicales.fr
Professions de santé
Pharmacologie
Pharmacologie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Efficacité des médicaments
Essais cliniques
Toxicité médicamenteuse
Tests de laboratoire
Interactions médicamenteuses
Antécédents médicaux
Surdose
Symptômes de surdose
Allergie médicamenteuse
Tests cutanés
Symptômes
5
Réaction allergique
Symptômes
Toxicité médicamenteuse
Signes cliniques
Interactions médicamenteuses
Effets secondaires
Prévention
5
Interactions médicamenteuses
Communication patient-médecin
Dépendance
Prescriptions médicales
Effets secondaires
Suivi médical
Médicaments pédiatriques
Dosage
Surdose
Éducation des patients
Traitements
5
Hypertension
Médicaments antihypertenseurs
Effets secondaires
Ajustement de dose
Douleur chronique
Analgésiques
Allergie médicamenteuse
Antihistaminiques
Complications
5
Interactions médicamenteuses
Risques
Lésions hépatiques
Hépatite médicamenteuse
Allergie médicamenteuse
Choc anaphylactique
Facteurs de risque
5
Interactions médicamenteuses
Antécédents médicaux
Dépendance
Antécédents familiaux
Toxicité médicamenteuse
Fonction hépatique
Efficacité des médicaments
Comorbidités
Effets secondaires
Maladies chroniques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Pharmacologie : Questions médicales les plus fréquentes",
"headline": "Pharmacologie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Pharmacologie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2026-06-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Pharmacologie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Professions de santé",
"url": "https://questionsmedicales.fr/mesh/D006281",
"about": {
"@type": "MedicalCondition",
"name": "Professions de santé",
"code": {
"@type": "MedicalCode",
"code": "D006281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Biopharmacie",
"alternateName": "Biopharmaceutics",
"url": "https://questionsmedicales.fr/mesh/D001702",
"about": {
"@type": "MedicalCondition",
"name": "Biopharmacie",
"code": {
"@type": "MedicalCode",
"code": "D001702",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.628.049"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Science des plantes médicinales",
"alternateName": "Herbal Medicine",
"url": "https://questionsmedicales.fr/mesh/D029001",
"about": {
"@type": "MedicalCondition",
"name": "Science des plantes médicinales",
"code": {
"@type": "MedicalCode",
"code": "D029001",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.628.190"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neuropharmacologie",
"alternateName": "Neuropharmacology",
"url": "https://questionsmedicales.fr/mesh/D009480",
"about": {
"@type": "MedicalCondition",
"name": "Neuropharmacologie",
"code": {
"@type": "MedicalCode",
"code": "D009480",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.628.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pharmacoépidémiologie",
"alternateName": "Pharmacoepidemiology",
"url": "https://questionsmedicales.fr/mesh/D017891",
"about": {
"@type": "MedicalCondition",
"name": "Pharmacoépidémiologie",
"code": {
"@type": "MedicalCode",
"code": "D017891",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.628.413"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pharmacogénétique",
"alternateName": "Pharmacogenetics",
"url": "https://questionsmedicales.fr/mesh/D010597",
"about": {
"@type": "MedicalCondition",
"name": "Pharmacogénétique",
"code": {
"@type": "MedicalCode",
"code": "D010597",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.628.479"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pharmacologie clinique",
"alternateName": "Pharmacology, Clinical",
"url": "https://questionsmedicales.fr/mesh/D010601",
"about": {
"@type": "MedicalCondition",
"name": "Pharmacologie clinique",
"code": {
"@type": "MedicalCode",
"code": "D010601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.628.512"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Psychopharmacologie",
"alternateName": "Psychopharmacology",
"url": "https://questionsmedicales.fr/mesh/D011600",
"about": {
"@type": "MedicalCondition",
"name": "Psychopharmacologie",
"code": {
"@type": "MedicalCode",
"code": "D011600",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.628.546"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Pharmacologie",
"alternateName": "Pharmacology",
"code": {
"@type": "MedicalCode",
"code": "D010600",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xin Wang",
"url": "https://questionsmedicales.fr/author/Xin%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK."
}
},
{
"@type": "Person",
"name": "Ming Yang",
"url": "https://questionsmedicales.fr/author/Ming%20Yang",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China."
}
},
{
"@type": "Person",
"name": "Xu Cao",
"url": "https://questionsmedicales.fr/author/Xu%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China."
}
},
{
"@type": "Person",
"name": "Xiaobin Zao",
"url": "https://questionsmedicales.fr/author/Xiaobin%20Zao",
"affiliation": {
"@type": "Organization",
"name": "Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China."
}
},
{
"@type": "Person",
"name": "Jing Yan",
"url": "https://questionsmedicales.fr/author/Jing%20Yan",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology, Jining Medical University, Jining, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies.",
"datePublished": "2023-09-20",
"url": "https://questionsmedicales.fr/article/37614168",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3tb01358h"
}
},
{
"@type": "ScholarlyArticle",
"name": "Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.",
"datePublished": "2024-06-19",
"url": "https://questionsmedicales.fr/article/38901879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/jitc-2024-009063"
}
},
{
"@type": "ScholarlyArticle",
"name": "Semiconducting Polymers for Cancer Immunotherapy.",
"datePublished": "2023-10-02",
"url": "https://questionsmedicales.fr/article/37712920",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/marc.202300496"
}
},
{
"@type": "ScholarlyArticle",
"name": "The future of affordable cancer immunotherapy.",
"datePublished": "2023-09-06",
"url": "https://questionsmedicales.fr/article/37736099",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1248867"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunotherapy and delivery systems for melanoma.",
"datePublished": "2024-09-17",
"url": "https://questionsmedicales.fr/article/39286868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2394252"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Professions de santé",
"item": "https://questionsmedicales.fr/mesh/D006281"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pharmacologie",
"item": "https://questionsmedicales.fr/mesh/D010600"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Pharmacologie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Pharmacologie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-25",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Pharmacologie",
"description": "Comment évaluer l'efficacité d'un médicament ?\nQuels tests pour détecter une toxicité médicamenteuse ?\nComment identifier une interaction médicamenteuse ?\nQuels signes indiquent une surdose ?\nComment diagnostiquer une allergie médicamenteuse ?",
"url": "https://questionsmedicales.fr/mesh/D010600?mesh_terms=Immunotherapy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Pharmacologie",
"description": "Quels symptômes d'une réaction allergique ?\nQuels signes d'une toxicité médicamenteuse ?\nComment reconnaître une dépendance médicamenteuse ?\nQuels symptômes d'une surdose d'opioïdes ?\nQuels signes d'une interaction médicamenteuse ?",
"url": "https://questionsmedicales.fr/mesh/D010600?mesh_terms=Immunotherapy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Pharmacologie",
"description": "Comment prévenir les interactions médicamenteuses ?\nQuelles mesures pour éviter la dépendance ?\nComment prévenir les effets secondaires ?\nQuelles précautions pour les médicaments chez les enfants ?\nComment éviter les surdoses accidentelles ?",
"url": "https://questionsmedicales.fr/mesh/D010600?mesh_terms=Immunotherapy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Pharmacologie",
"description": "Comment traiter une surdose médicamenteuse ?\nQuels médicaments pour l'hypertension ?\nComment gérer les effets secondaires d'un traitement ?\nQuels traitements pour la douleur chronique ?\nComment traiter une allergie médicamenteuse ?",
"url": "https://questionsmedicales.fr/mesh/D010600?mesh_terms=Immunotherapy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Pharmacologie",
"description": "Quelles complications d'une surdose ?\nQuels risques d'une interaction médicamenteuse ?\nQuelles complications liées à l'usage prolongé d'analgésiques ?\nQuels effets à long terme des médicaments sur le foie ?\nQuelles complications d'une allergie médicamenteuse ?",
"url": "https://questionsmedicales.fr/mesh/D010600?mesh_terms=Immunotherapy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Pharmacologie",
"description": "Quels facteurs de risque pour les interactions médicamenteuses ?\nQuels facteurs augmentent le risque de dépendance ?\nQuels facteurs de risque pour la toxicité médicamenteuse ?\nQuels facteurs influencent l'efficacité d'un médicament ?\nQuels facteurs de risque pour les effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D010600?mesh_terms=Immunotherapy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un médicament ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques et des essais contrôlés randomisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour détecter une toxicité médicamenteuse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, des analyses d'urine et des examens cliniques sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment identifier une interaction médicamenteuse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'interaction est identifiée par l'analyse des antécédents médicaux et des prescriptions."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, nausées, vomissements et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une allergie médicamenteuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic est établi par l'historique médical et des tests cutanés spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une réaction allergique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent éruptions cutanées, démangeaisons, et gonflement."
}
},
{
"@type": "Question",
"name": "Quels signes d'une toxicité médicamenteuse ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes peuvent inclure des nausées, des vertiges et des troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une dépendance médicamenteuse ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme le besoin compulsif et le sevrage indiquent une dépendance."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une surdose d'opioïdes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent dépression respiratoire, somnolence et perte de conscience."
}
},
{
"@type": "Question",
"name": "Quels signes d'une interaction médicamenteuse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes peuvent être des effets secondaires inattendus ou une efficacité réduite."
}
},
{
"@type": "Question",
"name": "Comment prévenir les interactions médicamenteuses ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne communication entre le patient et le médecin."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la dépendance ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter l'utilisation des médicaments à risque et suivre les prescriptions médicales."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets secondaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut le suivi régulier et l'ajustement des doses si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour les médicaments chez les enfants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des formulations adaptées et respecter les doses prescrites par le pédiatre."
}
},
{
"@type": "Question",
"name": "Comment éviter les surdoses accidentelles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éduquer les patients sur les doses et les risques associés aux médicaments."
}
},
{
"@type": "Question",
"name": "Comment traiter une surdose médicamenteuse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'administration d'antidotes et le soutien des fonctions vitales."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour l'hypertension ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les diurétiques, les bêta-bloquants et les inhibiteurs de l'ACE."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires d'un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'ajustement de la dose ou le changement de médicament si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la douleur chronique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les analgésiques, les anti-inflammatoires et la thérapie physique."
}
},
{
"@type": "Question",
"name": "Comment traiter une allergie médicamenteuse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à arrêter le médicament et à administrer des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une surdose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des lésions organiques, des troubles neurologiques et la mort."
}
},
{
"@type": "Question",
"name": "Quels risques d'une interaction médicamenteuse ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent une efficacité réduite ou des effets indésirables graves."
}
},
{
"@type": "Question",
"name": "Quelles complications liées à l'usage prolongé d'analgésiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage prolongé peut entraîner dépendance, tolérance et effets secondaires graves."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des médicaments sur le foie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets peuvent inclure des lésions hépatiques, une hépatite médicamenteuse et une cirrhose."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une allergie médicamenteuse ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure un choc anaphylactique et des lésions cutanées graves."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les interactions médicamenteuses ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le nombre de médicaments pris et les antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dépendance ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les troubles mentaux et l'usage prolongé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la toxicité médicamenteuse ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, la fonction hépatique et rénale altérée sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent l'efficacité d'un médicament ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le poids, le sexe et les comorbidités peuvent influencer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les effets secondaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les maladies chroniques et les interactions médicamenteuses."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/06/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Publications dans "Pharmacologie" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Publications dans "Pharmacologie" :
2 publications dans cette catégorie
Affiliations :
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Publications dans "Pharmacologie" :
2 publications dans cette catégorie
Affiliations :
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Publications dans "Pharmacologie" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Jining Medical University, Jining, China.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Forensic Toxicology, Environmental Health Division, Wisconsin State Laboratory of Hygiene, 2601 Agriculture Dr., Madison, Wisconsin 53718, USA.
Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave., Madison, Wisconsin 53705, USA.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave., Madison, Wisconsin 53705, USA.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Forensic Toxicology, Environmental Health Division, Wisconsin State Laboratory of Hygiene, 2601 Agriculture Dr., Madison, Wisconsin 53718, USA.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab 147002 India.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmacology, M. M. College of Pharmacy, M. M. (Deemed to be University), Mullana, Ambala, Haryana India.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab 147002 India.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab 147002 India.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada. nrosen@dal.ca.
Department of Obstetrics and Gynaecology, Dalhousie University, Halifax, NS, Canada. nrosen@dal.ca.
Departments of Psychology and Neuroscience, Dalhousie University, 1355 Oxford Street, P.O. Box 15000, Halifax, NS, B3H 4R2, Canada. nrosen@dal.ca.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, Dalhousie University, Halifax, NS, Canada.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, Drexel University College of Medicine, Philadelphia, PA, USA.
Center for Pelvic Medicine, Bryn Mawr, PA, USA.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Susan Samueli Integrative Health Institute, College of Health Sciences, University of California-Irvine, Irvine, CA 92617, USA.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Susan Samueli Integrative Health Institute, College of Health Sciences, University of California-Irvine, Irvine, CA 92617, USA.
Publications dans "Pharmacologie" :
1 publication dans cette catégorie
Affiliations :
Susan Samueli Integrative Health Institute, College of Health Sciences, University of California-Irvine, Irvine, CA 92617, USA.
Publications dans "Pharmacologie" :
Immunotherapy is a new type of tumor treatment after surgery, radiotherapy and chemotherapy, and can be used to manage and destroy tumor cells through activating or strengthening the immune response. ...
Cancer immunotherapy has flourished over the last 10-15 years, transforming the practice of oncology and providing long-term clinical benefit to some patients. During this time, three distinct classes...
As a monumental breakthrough in cancer treatment, immunotherapy has attracted tremendous attention in recent years. However, one challenge faced by immunotherapy is the low response rate and the immun...
The treatment of cancer was revolutionized within the last two decades by utilizing the mechanism of the immune system against malignant tissue in so-called cancer immunotherapy. Two main developments...
Melanoma is a highly malignant tumor of melanocyte origin that is prone to early metastasis and has a very poor prognosis. Early melanoma treatment modalities are mainly surgical, and treatment strate...
Immune-checkpoint inhibitors (ICIs) are now widely used for the treatment of patients with advanced-stage hepatocellular carcinoma (HCC). Two different ICI-containing regimens, atezolizumab plus bevac...
Esophageal cancer (EC), a common type of malignant tumor, ranks as the sixth highest contributor to cancer-related mortality worldwide. Due to the condition that most patients with EC are diagnosed at...
Immune checkpoint inhibitors are increasingly important in the treatment algorithm for locally advanced and metastatic bladder cancer. Numerous ongoing studies are investigating these agents as first-...
To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma....
We performed a comprehensive search including the Cochrane Library, MEDLINE, Embase, three other databases, several trial registers, other sources of gray literature, and conference proceedings, with ...
We included randomized controlled trials (RCTs) using immunotherapy versus chemotherapy and would have considered non-randomized trials in the absence of randomized trial data. Participants had locall...
Two review authors independently classified studies for inclusion and abstracted data from included studies. We performed statistical analyses using a random-effects model and interpreted them accordi...
We included five RCTs and identified seven single-armed studies. The RCTs included 3572 participants comparing immunotherapy versus chemotherapy for the treatment of locally advanced and metastatic bl...
Compared to chemotherapy, immunotherapy for treating advanced or metastatic urothelial carcinoma probably has little to no effect on the risk of death from any cause when used as first-line therapy. S...
Supramolecular immunotherapy employs supramolecular materials to stimulate the immune system for inhibiting tumor cell growth and metastasis, reducing the cancer recurrence rate, and improving the qua...
A quarter century has passed since the milestone study by Mazzaferro and colleagues on liver transplantation (LT) for hepatocellular carcinoma (HCC). The increasing demand for LT for HCC has led to th...